Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Ensem Therapeutics
Atavistik Bio, Inc
Eisai Inc.
NeoImmuneTech
Alterome Therapeutics, Inc.
Psyence Australia Pty Ltd
Eli Lilly and Company
ViroMissile, Inc.
Replimune Inc.
Tizona Therapeutics, Inc
A2 Biotherapeutics Inc.
AstraZeneca
Angiex, Inc.
Stemline Therapeutics, Inc.
Iambic Therapeutics, Inc
DualityBio Inc.
AstraZeneca
EXoPERT
AstraZeneca
Onchilles Pharma Inc
Tolmar Inc.
Ocellaris Pharma, Inc.
Tolmar Inc.
EXoPERT
Elephas
Eli Lilly and Company
Novartis
BriaCell Therapeutics Corporation
Var2 Pharmaceuticals
OncoNano Medicine, Inc.
GlaxoSmithKline
AbbVie
AstraZeneca
Bayer
Massive Bio, Inc.
Rondo Therapeutics
Eli Lilly and Company
Hummingbird Bioscience
AstraZeneca
AVM Biotechnology Inc
Sanofi
Nurix Therapeutics, Inc.
A2 Biotherapeutics Inc.
Palleon Pharmaceuticals, Inc.
Exelixis
AbbVie
Medicenna Therapeutics, Inc.
Boehringer Ingelheim
Bristol-Myers Squibb